Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Hum Mutat ; 37(9): 847-64, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27302555

RESUMEN

Kabuki syndrome (KS) is a rare but recognizable condition that consists of a characteristic face, short stature, various organ malformations, and a variable degree of intellectual disability. Mutations in KMT2D have been identified as the main cause for KS, whereas mutations in KDM6A are a much less frequent cause. Here, we report a mutation screening in a case series of 347 unpublished patients, in which we identified 12 novel KDM6A mutations (KS type 2) and 208 mutations in KMT2D (KS type 1), 132 of them novel. Two of the KDM6A mutations were maternally inherited and nine were shown to be de novo. We give an up-to-date overview of all published mutations for the two KS genes and point out possible mutation hot spots and strategies for molecular genetic testing. We also report the clinical details for 11 patients with KS type 2, summarize the published clinical information, specifically with a focus on the less well-defined X-linked KS type 2, and comment on phenotype-genotype correlations as well as sex-specific phenotypic differences. Finally, we also discuss a possible role of KDM6A in Kabuki-like Turner syndrome and report a mutation screening of KDM6C (UTY) in male KS patients.


Asunto(s)
Anomalías Múltiples/genética , Proteínas de Unión al ADN/genética , Cara/anomalías , Enfermedades Hematológicas/genética , Histona Demetilasas/genética , Mutación , Proteínas de Neoplasias/genética , Proteínas Nucleares/genética , Enfermedades Vestibulares/genética , Anomalías Múltiples/patología , Cara/patología , Femenino , Genes Ligados a X , Predisposición Genética a la Enfermedad , Enfermedades Hematológicas/patología , Humanos , Masculino , Herencia Materna , Síndrome de Noonan/genética , Análisis de Secuencia de ADN , Enfermedades Vestibulares/patología
2.
J Med Genet ; 50(2): 91-8, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23339108

RESUMEN

BACKGROUND: Asphyxiating Thoracic Dysplasia (ATD) belongs to the short rib polydactyly group and is characterized by a narrow thorax, short long bones and trident acetabular roof. Other reported features include polydactyly, renal, liver and retinal involvement. To date, mutations in IFT80, DYNC2H1, TTC21B and WDR19 have been reported in ATD. The clinical and molecular heterogeneity leads to difficulties in the evaluation of the long-term prognosis. METHODS: We investigated 53 ATD cases (23 living cases and 30 fetuses) from 39 families. They benefited from a combined approach of deep phenotyping and IFT80 and DYNC2H1 molecular screening. RESULTS: Among the 23 postnatal cases, pulmonary insufficiency was noted in 60% of cases, with tracheotomy requirement in five cases. Renal and liver diseases occurred respectively in 17% and 22% of cases, whereas retinal alteration was present in 50% of cases aged more than 5 years. We identified DYNC2H1 mutations in 23 families (59%) and IFT80 mutations in two families (5%). However, in six families, only one heterozygote mutation in either IFT80 or DYNC2H1 was identified. Finally, the two genes were excluded in 14 families (36%). CONCLUSIONS: We conclude that DYNC2H1 is a major gene responsible for ATD, while IFT80 is rarely involved. The presence of only one mutation in six families and the exclusion of the two genes in 14 families support the involvement of other causal cilia genes. The long-term follow up emphasizes that the pulmonary prognosis is probably less pejorative and retinal involvement more frequent than previously thought.


Asunto(s)
Síndrome de Ellis-Van Creveld/genética , Aborto Inducido , Adolescente , Adulto , Niño , Preescolar , Dineínas Citoplasmáticas/genética , Síndrome de Ellis-Van Creveld/diagnóstico , Síndrome de Ellis-Van Creveld/diagnóstico por imagen , Síndrome de Ellis-Van Creveld/patología , Femenino , Feto/anomalías , Francia , Genotipo , Humanos , Lactante , Masculino , Persona de Mediana Edad , Mutación , Fenotipo , Ultrasonografía Prenatal
3.
J Pediatr ; 163(3): 742-6, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23535010

RESUMEN

OBJECTIVE: To determine the frequency and types of renal malformations, and to evaluate renal function in a cohort of patients with Kabuki syndrome (KS). STUDY DESIGN: Renal ultrasound scans and plasma creatinine measurements were collected from a French cohort of 94 patients with genotyped KS. Renal function was evaluated based on the estimated glomerular filtration rate. A genotype-phenotype study was conducted for renal and urinary tract malformations. RESULTS: Renal malformations were present in 22% of cases, and urinary tract anomalies were present in 15%. Renal malformations were observed in 28% of the MLL2 mutation-positive group and in 0% of the MLL2 mutation-negative group (P = .015). No correlation was found between the presence or absence of renal or urinary tract malformations and the location or type of MLL2 mutation. Renal function was normal except for 1 patient with a MLL2 mutation diagnosed in the first days of life and severe renal disease due to unilateral renal agenesia and controlateral severe hypoplasia that progressed to the terminal stage at age 2 years. CONCLUSION: Our study emphasizes the need for ultrasound and renal function screening in children diagnosed with KS.


Asunto(s)
Anomalías Múltiples/diagnóstico , Enfermedades Hematológicas/diagnóstico , Riñón/anomalías , Enfermedades Vestibulares/diagnóstico , Anomalías Múltiples/sangre , Anomalías Múltiples/genética , Anomalías Múltiples/fisiopatología , Adolescente , Adulto , Biomarcadores/sangre , Niño , Preescolar , Estudios de Cohortes , Creatinina/sangre , Proteínas de Unión al ADN/genética , Cara/anomalías , Cara/fisiopatología , Femenino , Francia , Estudios de Asociación Genética , Marcadores Genéticos , Técnicas de Genotipaje , Tasa de Filtración Glomerular , Enfermedades Hematológicas/sangre , Enfermedades Hematológicas/genética , Enfermedades Hematológicas/fisiopatología , Histona Demetilasas/genética , Humanos , Lactante , Riñón/diagnóstico por imagen , Riñón/metabolismo , Riñón/fisiopatología , Masculino , Proteínas de Neoplasias/genética , Proteínas Nucleares/genética , Estudios Retrospectivos , Ultrasonografía , Enfermedades Vestibulares/sangre , Enfermedades Vestibulares/genética , Enfermedades Vestibulares/fisiopatología , Adulto Joven
4.
Eur J Med Genet ; 56(10): 556-60, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23933090

RESUMEN

Kabuki syndrome (KS) is a rare syndrome associating malformations with intellectual deficiency and numerous visceral, orthopedic, endocrinological, immune and autoimmune complications. The early establishment of a diagnostic of KS leads to better care of the patients and therefore prevents complications such as perception deafness, severe complications of auto-immune diseases or obesity. However, the diagnosis of KS remains difficult because based on the appreciation of facial features combined with other highly variable features. We describe a novel sign, namely the attenuation and/or congenital absence of the IPD crease of the third and fourth fingers associated with limitation of flexion of the corresponding joints, which seems to be specific of KS and could help the clinician to diagnose KS.


Asunto(s)
Anomalías Múltiples/diagnóstico , Cara/anomalías , Dedos/anomalías , Enfermedades Hematológicas/diagnóstico , Enfermedades Vestibulares/diagnóstico , Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino
5.
Eur J Endocrinol ; 166(2): 333-9, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22048969

RESUMEN

CONTEXT: Congenital hyperinsulinism (HI) is a common cause of hypoglycemia in infancy. The medical treatment of diazoxide-unresponsive HI is based on a somatostatin analogue. OBJECTIVE: This study aims at replacing three daily s.c. octreotide (Sandostatin, Novartis) injections by a single and monthly i.m. injection of long-acting release (LAR) octreotide (Sandostatin LP, Novartis) in HI patients. SUBJECTS AND METHOD: LAR octreotide was injected every 4 weeks during 6 months and s.c. octreotide injections were stopped after the third injection of LAR octreotide. After this 6-month study, LAR octreotide was continued, with an average follow-up of 17 months. Ten HI pediatric patients unresponsive to diazoxide and currently treated with s.c. octreotide were included in the trial. Glycemias and other parameters (HbA1c, IGF1, height, weight, quality of life (QoL), and satisfaction) were monitored at each monthly visit. RESULTS: For all ten patients, glycemias were maintained in the usual range, HbAlc (mean 5.5%; 95% CI: 4.6-6.2) and IGF1 (mean 89.7 ng/ml; 95% CI: 26-153) were unchanged. Patients gained height significantly (mean 2.7 cm; 95% CI: 1.9-3.4) and no side effect was noted during the study and the later follow-up. Plasma octreotide levels were stable under LAR octreotide. Parents' questionnaires of general satisfaction were highly positive whereas children's QoL evaluation remained unchanged. CONCLUSION: In these diazoxide-unresponsive HI patients, LAR octreotide was efficient, well tolerated and contributed to a clear simplification of the medical care.


Asunto(s)
Hiperinsulinismo Congénito/tratamiento farmacológico , Octreótido/administración & dosificación , Transportadoras de Casetes de Unión a ATP/genética , Niño , Preescolar , Hiperinsulinismo Congénito/sangre , Hiperinsulinismo Congénito/genética , Hiperinsulinismo Congénito/metabolismo , Preparaciones de Acción Retardada , Femenino , Estudios de Seguimiento , Fármacos Gastrointestinales/administración & dosificación , Fármacos Gastrointestinales/efectos adversos , Humanos , Lactante , Inyecciones Intramusculares/efectos adversos , Inyecciones Subcutáneas/efectos adversos , Masculino , Octreótido/efectos adversos , Octreótido/sangre , Octreótido/farmacocinética , Canales de Potasio de Rectificación Interna/genética , Receptores de Droga/genética , Receptores de Sulfonilureas , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA